Biotechnology Industry Analysis and Statistics (since 2008

Exact Sciences Corporation - Financial and Strategic Analysis ReviewSummaryEXACT Sciences Corporation is an applied genomics company engaged in the development of deoxyribonucleic acid (DNA)-based technologies used in the detection of cancer. It principally focuses on the identification of colorecta ...

Industries : Biotechnology

Evotec Aktiengesellschaft - Financial and Strategic Analysis Review

$ 125
April 2009

Evotec Aktiengesellschaft - Financial and Strategic Analysis ReviewSummaryEvotec Aktiengesellschaft (Evotec) is a biopharmaceutical company principally engaged in discovering and developing small molecule drugs. The company?s proprietary platform targets central nervous system related diseases and p ...

Industries : Biotechnology

GammaCan International Inc - Financial and Strategic Analysis Review

$ 125
April 2009

GammaCan International Inc - Financial and Strategic Analysis ReviewSummaryGammaCan International, Inc. (GammaCan) is a life science company engaged in developing proprietary immunotherapies for the treatment of melanoma and other cancers. Its patented platform technology is based on the use of IgGs ...

Industries : Biotechnology

Alizyme plc - Financial and Strategic Analysis Review

$ 125
April 2009

Alizyme plc - Financial and Strategic Analysis ReviewSummaryAlizyme plc is a biopharmaceutical development company focused on the therapeutic areas of metabolic disorders, gastrointestinal disorders and cancer supportive care. The company is engaged in developing products for the treatment and manag ...

Industries : Biotechnology

Genelabs Technologies, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Genelabs Technologies, Inc. - Financial and Strategic Analysis ReviewSummaryGenelabs Technologies, Inc. (Genelabs) is a biopharmaceutical company engaged in discovering and developing pharmaceutical products to improve human health. The company focuses on discovering novel compounds that reduce repl ...

Industries : Biotechnology

Genetic Technologies Limited - Financial and Strategic Analysis Review

$ 125
April 2009

Genetic Technologies Limited - Financial and Strategic Analysis ReviewSummaryGenetic Technologies Limited (Genetic), a life science company, specializes in the field of genetics and genomics. It principally operates in four segments: licensing, testing, research and corporate. It specializes in lice ...

Industries : Biotechnology

GENTIUM S.p.A. - Financial and Strategic Analysis Review

$ 125
April 2009

GENTIUM S.p.A. - Financial and Strategic Analysis ReviewSummaryGentium S.p.A. (Gentium) is a biopharmaceutical company, engaged in the discovery, development, and manufacture of drugs derived form the natural sources. The drugs are being developed to treat various vascular diseases and for condition ...

Industries : Biotechnology

GeoVax Labs, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

GeoVax Labs, Inc. - Financial and Strategic Analysis ReviewSummaryGeoVax Labs, Inc. (GeoVax) is a clinical stage biotechnology company focusing on research and development activities with a goal to develop, license and commercialize the manufacture and sale of human vaccines for diseases caused by H ...

Industries : Biotechnology

Agenix ltd. - Financial and Strategic Analysis Review

$ 125
April 2009

Agenix ltd. - Financial and Strategic Analysis ReviewSummaryAgenix Limited is a pharmaceutical company engaged in the development of monoclonal antibody-based product and the advanced medical diagnostics agents. The company runs its business through its two subsidiaries Agen Biomedical and Agenix Ph ...

Industries : Biotechnology

Cougar Biotechnology, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Cougar Biotechnology, Inc. - Financial and Strategic Analysis ReviewSummaryCougar Biotechnology, Inc.(Cougar Biotechnology) is a developmental stage company engaged in in-licensing and developing clinical stage pharmaceutical products for treatment of Cancer for commercial use. The company has right ...

Industries : Biotechnology

ENZO BIOCHEM, INC - Financial and Strategic Analysis Review

$ 125
April 2009

ENZO BIOCHEM, INC - Financial and Strategic Analysis ReviewSummaryEnzo Biochem, Inc. is engaged in developing new products and technologies in life science and biotechnology industry. It focuses on developing research tools, diagnostics and therapeutics and providing diagnostic services to the medi ...

Industries : Biotechnology

Immunomedics, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Immunomedics, Inc. - Financial and Strategic Analysis ReviewSummaryImmunomedics, Inc. is a biopharmaceutical company engaged in the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It developed a number of advanced prop ...

Industries : Biotechnology

Idera Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Idera Pharmaceuticals, Inc. - Financial and Strategic Analysis ReviewSummaryIdera Pharmaceuticals, Inc. (Idera) is a biotechnology company focusing on the discovery and development of synthetic deoxyribonucleic acid (DNA)-and ribonucleic acid (RNA)-based drug candidates targeted to Toll-Like Recepto ...

Industries : Biotechnology

IR Biosciences Holdings, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

IR Biosciences Holdings, Inc. - Financial and Strategic Analysis ReviewSummaryIR Biosciences Holdings, Inc. is a development stage biotechnology company. The company through its wholly-owned subsidiary ImmuneRegen BioSciences, Inc. is engaged in the research and development of potential drug candida ...

Industries : Biotechnology

Averion International Corp. - Financial and Strategic Analysis Review

$ 125
April 2009

Averion International Corp. - Financial and Strategic Analysis ReviewSummaryAverion International Corp. (Averion) is an international clinical research organization that provides clinical research services and solutions to the pharmaceutical, biotechnology and medical device industries and it manage ...

Industries : Biotechnology

Avita Medical Ltd - Financial and Strategic Analysis Review

$ 125
April 2009

Avita Medical Ltd - Financial and Strategic Analysis ReviewSummaryAvita Medical Ltd is a biomedical company that develops and distributes products in the high growth, fast developing fields of Respiratory and Regenerative Medicine. The company products include ReCell CellSpray Funhaler and Breath-A- ...

Industries : Biotechnology

Lescarden Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Lescarden Inc. - Financial and Strategic Analysis ReviewSummaryLescarden Inc. is a biotechnology company principally engaged in the research and development of proprietary therapy products with focus on clinical skin care, wound healing, osteoarthritis, cancer and autoimmune applications. The compan ...

Industries : Biotechnology

Lipid Sciences, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Lipid Sciences, Inc. - Financial and Strategic Analysis ReviewSummaryLipid Sciences, Inc. is a development-stage biotechnology company principally engaged in the research and development of therapeutics for cardiovascular disease based on its HDL therapy platform (HDL Mimetic Peptides and HDL select ...

Industries : Biotechnology

Mymetics Corporation - Financial and Strategic Analysis Review

$ 125
April 2009

Mymetics Corporation - Financial and Strategic Analysis ReviewSummaryMymetics Corporation is a biotechnology company focused on the fundamental and research areas of human biology and medicine. It is intending to develop vaccines and therapies for the prevention and treatment of certain retroviruses ...

Industries : Biotechnology

Genentech, Inc. - Financial and Strategic Analysis Review

$ 125
April 2009

Genentech, Inc. - Financial and Strategic Analysis ReviewSummaryGenentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of biotherapeutics. The company has principal operations in the US. Genentech is developing the drugs across the un ...

Industries : Biotechnology

The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses

$ 3 835
April 2009

Biologics continue to outperform the global pharma market, driven by premium priced therapies for conditions that cannot be managed by conventional drugs. The rapid penetration of novel biologics and the gradual expiry of their patents will create significant market opportunities for biosimilars dev ...

Industries : Biotechnology, Pharmaceutical

Worldwide Nanotechnology Dental Implant Market Shares, Strategies, and Forecasts, 2009 to 2015

$ 3 400
April 2009

Worldwide dental implants are poised to achieve significant growth as patients become aware of the health benefits achieved from having viable teeth. Dental implants are in the category of optional surgery and represent the type of consumer spending that is postponed in challenging economic environm ...

Industries : Biotechnology

Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024

$ 2 501
April 2009

There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success ? our new report explains howRevenues for biologic drugs reached approximately $125bn in 2008. Patents on most current biologics have expired or will ...

Industries : Biotechnology

Competitor Analysis: PARP Inhibitors

$ 125
April 2009

Product description The present Competitive Intelligence Report about PARP Inhibitors provides a competitor evaluation in the field of investigational small molecules inhibiting poly-adenyl-ribose polymerase (PARP) for treatment of cancer as of April 2009. Poly (ADP-ribose) polymera ...

Industries : Biopharmaceutical

Practical Guide to Finding Partners in Pharma and Biotech

$ 1 011
April 2009

CurrentPartnering?s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity.The report takes the reader through the practical steps required to prepare for part ...

Industries : Biotechnology, Pharmaceutical

Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development

$ 3 800
April 2009

IntroductionHematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens. Nowadays, it has a range of applications, including the treatment of certain hematologic malignanci ...

Industries : Biotechnology

Competitor Analysis: EpCAM Antagonists

$ 125
April 2009

Product description The present Competitive Intelligence Report about EpCAM Antagonists provides a competitor evaluation in the field of investigational antibodies and antibody-based constructs targeting epithelial cell adhesion molecule (EpCAM) for treatment of cancer as of April 2009. Epith ...

Industries : Biopharmaceutical

Stem Cells ? The Hype & Hope ? World Analysis 2009-2024

$ 2 501
March 2009

Stem cells represent one of the most promising medical breakthroughs of all time, as our new market report explains. Currently, in 2009, the new US administration is lifting some major restrictions on stem cells technologies. This developmental obstacle now removed, all types of stem cells are avail ...

Industries : Biotechnology

Option and Evaluation Agreements in Pharma and Biotech

$ 1 447
March 2009

Report description The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.This report provides details of the latest o ...

Industries : Biotechnology, Pharmaceutical

South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

$ 2 500
March 2009
101 pages

South Africa Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to the South Africa patient monitoring devices market. It also offers detailed and comprehensive coverage of market revenue, vo ...

Industries : Biotechnology, Surgical Equipment

<<
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
>>

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.